Blog Posts focused on: Type 1 Diabetes (T1D); Type 1 Diabetes TrialNet
Wimpress Family Battles Diabetes, Supports Research
In the 1950s, when Jack Wimpress, a talented Boeing aerodynamics engineer, and his late wife, Doris, a dedicated nurse, began their family, they were a statistical anomaly. “Three out of four of our children developed type 1 diabetes,” says Jack. “Everyone told us that this wasn’t possible.”
New Hope for T1D Early Intervention
For most people, the onset of type 1 diabetes (T1D) seems to occur suddenly, often resulting in a trip to the emergency room with life-threatening complications.
Gene Editing Aims to Control T1D
Benaroya Research Institute (BRI) and Seattle Children’s Research Institute (SCRI) are pioneering the use of gene editing techniques in efforts to control type 1 diabetes (T1D).
Elite Soccer Player Contributes to Research
In March of 2015, 13-year-old Lizzie Blockhus experienced a week of being very tired and not feeling well. “I woke up in the middle of night and was dying of thirst,” she explains. “Then I was at my sister’s soccer game, dying of thirst again and I knew something wasn’t right.
New Leadership Role
Benaroya Research Institute (BRI) has been awarded another leadership role in type 1 diabetes research. Carla Greenbaum, MD, BRI’s director of the Diabetes Research Program and Clinical Research Center, has been named chair of Type 1 Diabetes TrialNet.
Working To Eliminate Type 1 Diabetes
In clinical trials, not all individuals respond in the same way to particular immunological therapies.
Unraveling Insulin Mystery in Diabetes
Researchers have found at the time of diagnosis with type 1 diabetes that many people continue to produce small amounts of insulin.
Honoring a Friend While Funding Research
A labor of love to honor a much loved man provides funds for type 1 diabetes research at Benaroya Research Institute at Virginia Mason (BRI). The annual David J. Fanning Memorial Golf Tournament has raised nearly $200,000 since its inception in 2011.
Leading a Biomarker Center To Fight Type 1 Diabetes
Biomarkers are key tools for scientists studying autoimmune and other diseases. A biomarker is a measurable characteristic that reflects a normal biological process or disease state.
Dvoraks Fund Autoimmune Disease Research
As a young man, Frank Dvorak had set his sights on a career in aviation. He was in his senior year at the Royal Military College of Canada when he received the life-changing diagnosis: type 1 diabetes. Because of his disease, he was grounded from flying.